Stryker Launches T2 Alpha Femur Retrograde Nailing System
August 24, 2021 at 08:05 am EDT
Share
Stryker has announced the launch of its T2 Alpha Femur Retrograde Nailing System. The new nailing solution features a redefined data-driven nail design, an advanced locking screw option that provides surgeons with axial stability where desired, and a dedicated proximal targeting system, which may reduce the number of X-ray shots compared to freehand locking. The T2 Alpha Femur Retrograde Nailing System was created with a new level of innovation, including: Data-driven Stryker Orthopaedic Modeling and Analytics (SOMA) designed nails, available in a variety of sizes and radii of curvature, to meet the unique needs of each case and diverse anatomical patient needs. Advanced locking screws that are designed to limit relative motion between the nail and screw and provide additional stability when needed. Guided targeting that is designed to provide more reproducible locking and reduce the number of X-ray shots compared to freehand locking. Intuitive instrumentation that is inspired by surgeon preferences and designed to improve ease of use, case after case.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).